Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

The report "Hospital Filtration Market by Type (Point of Use Filters, Inline Filters, Standalone Filtration Units, Disposable ...

Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.

Drug major Merck & Co. (MRK) announced Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use or ...

(RTTNews) - Merck & Co Inc. (MRK), Thursday said it has decided to stop the Phase 3 HYPERION study evaluating Winrevair in pulmonary arterial hypertension (PAH). The HYPERION study is designed to ...

One of the initial breakthroughs in microRNA research was the discovery of these small RNA molecules. In the early 2000s, researchers identified the existence of a large number of microRNAs in various ...

Merck Research Laboratories. “Today’s U.S. filing acceptance demonstrates our commitment to advancing novel therapies, such as WELIREG, to help treat patients with certain rare oncologic diseases. We ...

Merck Research Laboratories, said: “Data from phase 2 studies has provided compelling clinical evidence that warrants further evaluation of efinopegdutide for the treatment of NASH.” ...

The analysis encompasses the assessment of research design, data collection techniques, sampling methods, and data analysis tools utilized in the study. By examining these elements, the analysis ...

Kennedy Jr., President Trump’s nominee to be health secretary, would have oversight power over the vaccine’s maker, Merck ... more than 20 years of research and development, continues to ...